First-in-class Epilepsy Treatment Fycompa(R) (perampanel) Launches in Jordan, Kingdom of Saudi Arabia and the United Arab Emirates

HATFIELD, England, January 4, 2017/PRNewswire/ — Fycompa(R) (perampanel) is now licensed for adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures in Jordan, Kingdom of Saudi Arabia and the United Arab Emirates.[1],[2],[3] Additionally, it is indicated in the United Arab Emirates for the adjunctive treatment of primary generalised tonic-clonic seizures in patients with […]